Company Overview
- Headquarters
- 100 Northern Avenue, Boston MA
- Website
- alyspharma.com
- Employees
- 5
- Industry
- BioTech/Drugs
Who is Alys Pharmaceuticals
Alys Pharmaceuticals is a biotechnology company based in Boston, Massachusetts. Founded in February 2024, Alys is a relatively small company with five employees. Alys Pharmaceuticals specializes in immuno-dermatology, focusing on developing innovative treatments for a range of skin conditions. Their pipeline includes programs and platforms targeting multiple dermatological indications. The company aims to address significant unmet medical needs in dermatology and transform the treatment paradigms for prevalent skin diseases. Alys Pharmaceuticals emerged from the consolidation of six asset-centric companies under the Medixci umbrella. This integration has resulted in a robust portfolio of assets and platforms, acquired from companies like Aldena Therapeutics, Graegis Pharmaceuticals, Granular Therapeutics, Klirna Biotech, Nira Biosciences, and Vimela Therapeutics. To learn more about Alys Pharmaceuticals and their innovative research, visit their website at alyspharma.com.
Company Leadership
Companies Similar to Alys Pharmaceuticals
Analyze industry trends and opportunities by examining competitors and companies comparable to Alys Pharmaceuticals, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 803 | Deerfield, IL | 2010 | ||
| Buffalo, NY | ||||